Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Kootenai Cancer Center

2003 Lincoln Way     
Coeur d'Alene , ID 83814
USA

 

Principal Investigator:
Brian Samuels, MD
Contact:
208 666 2295 Robin Gustin Study coordinator rgustin@kmc.org
Activation Status of this Site:
Closed
Notes about this Site:
Kootenai Cancer Center Website:
http://www.kootenaihealth.org/index.asp?w=pages&r=26&pid=29

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.